Published in J Med Ethics on November 11, 2010
Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer? Hum Reprod (2013) 1.07
Social and ethical issues in mitochondrial donation. Br Med Bull (2015) 0.93
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy. Hum Reprod (2016) 0.92
Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology. Eur J Hum Genet (2013) 0.87
The (Re) Production of the Genetically Related Body in Law, Technology and Culture: Mitochondria Replacement Therapy. Health Care Anal (2016) 0.85
Rendered invisible? The absent presence of egg providers in U.K. debates on the acceptability of research and therapy for mitochondrial disease. Monash Bioeth Rev (2015) 0.85
Emerging aspects of treatment in mitochondrial disorders. J Inherit Metab Dis (2015) 0.79
Mitochondrial replacement techniques: egg donation, genealogy and eugenics. Monash Bioeth Rev (2016) 0.78
Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol (2016) 0.77
Mitochondrial donation and 'the right to know'. J Med Ethics (2016) 0.75
Ethical aspects of nuclear and mitochondrial DNA transfer. Linacre Q (2016) 0.75
Are there moral differences between maternal spindle transfer and pronuclear transfer? Med Health Care Philos (2017) 0.75
I. The moral status of the pre-implantation embryo. Hum Reprod (2001) 1.73
ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod (2008) 1.59
Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod (2004) 1.53
Cross border reproductive care in six European countries. Hum Reprod (2010) 1.25
Ooplasmic and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues. Hum Reprod Update (2008) 1.21
The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost (2006) 1.18
ESHRE's good practice guide for cross-border reproductive care for centers and practitioners. Hum Reprod (2011) 1.10
ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod (2007) 0.97
Reproductive tourism as moral pluralism in motion. J Med Ethics (2002) 0.96
PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Hum Reprod (2008) 0.96
Oocyte cryopreservation for age-related fertility loss. Hum Reprod (2012) 0.95
Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update (2007) 0.94
ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod (2006) 0.94
Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod (2010) 0.93
ESHRE Task Force on Ethics and Law 12: oocyte donation for non-reproductive purposes. Hum Reprod (2007) 0.92
Oocyte donation for stem cell research. Hum Reprod (2006) 0.90
Infertility patients' beliefs about their embryos and their disposition preferences. Hum Reprod (2009) 0.90
Providing infertility treatment in resource-poor countries. Hum Reprod (2009) 0.90
ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues. Hum Reprod (2014) 0.88
ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons. Hum Reprod (2013) 0.87
Intrafamilial medically assisted reproduction. Hum Reprod (2011) 0.84
ESHRE Task Force on Ethics and Law 10: surrogacy. Hum Reprod (2005) 0.83
Reproductive decision-making in the context of mitochondrial DNA disorders: views and experiences of professionals. Clin Genet (2010) 0.82
To continue or discontinue storage of cryopreserved embryos? Patients' decisions in view of their child wish. Hum Reprod (2011) 0.82
Parenthood should be regarded as a right. Arch Dis Child (2005) 0.81
Reflections by patients who undergo IVF on the use of their supernumerary embryos for science. Reprod Biomed Online (2010) 0.80
Patients' conceptualization of cryopreserved embryos used in their fertility treatment. Hum Reprod (2009) 0.80
Nuclear transfer to prevent mitochondrial DNA disorders: revisiting the debate on reproductive cloning. Reprod Biomed Online (2010) 0.80
Taskforce 5: preimplantation genetic diagnosis. Hum Reprod (2003) 0.80
Trends in embryo disposition decisions: patients' responses to a 15-year mailing program. Hum Reprod (2011) 0.79
II. The cryopreservation of human embryos. Hum Reprod (2001) 0.78
Beyond sperm cells: a qualitative study on constructed meanings of the sperm donor in lesbian families. Hum Reprod (2014) 0.78
Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of embryos. Hum Reprod (2005) 0.75
[Care for addicted, pregnant women: justification for pressure and coercion]. Tijdschr Psychiatr (2012) 0.75
Lesbian couples' views about and experiences of not being able to choose their sperm donor. Cult Health Sex (2014) 0.75
HLA-matched embryos selected for siblings requiring haematopoietic stem cell transplantation: a psychological perspective. Reprod Biomed Online (2005) 0.75
[Hemoglobinopathies in The Netherlands; is screening of foreign women advisable?]. Ned Tijdschr Geneeskd (1992) 0.75